Quantitative structure activities relationships of some 2-mercaptoimidazoles as CCR2 inhibitors using genetic algorithm-artificial neural networks
- PMID: 24019819
- PMCID: PMC3764681
Quantitative structure activities relationships of some 2-mercaptoimidazoles as CCR2 inhibitors using genetic algorithm-artificial neural networks
Abstract
Quantitative relationships between structures of twenty six of 2-mercaptoimidazoles as C-C chemokine receptor type 2 (CCR2) inhibitors were assessed. Modeling of the biological activities of compounds of interest as a function of molecular structures was established by means of genetic algorithm multivariate linear regression (GA-MLR) and genetic algorithm (GA-ANN). The results showed that, the pIC50 values calculated by GA-ANN are in good agreement with the experimental data, and the performance of the artificial neural networks regression model is superior to the multivariate linear regression-based (MLR) model. With respect to the obtained results, it can be deduced that there is a non-linear relationship between the pIC50 s and the calculated structural descriptors of the 2-mercaptoimidazoles. The obtained models were able to describe about 78% and 93% of the variance in the experimental activity of molecules in training set, respectively. The study provided a novel and effective approach for predicting biological activities of 2-mercaptoimidazole derivatives as CCR2 inhibitors and disclosed that combined genetic algorithm and GA-ANN can be used as a powerful chemometric tools for quantitative structure activity relationship (QSAR) studies.
Keywords: 2-mercaptoimidazoles; Artificial neural networks; CCR2 inhibitors; Multivariate linear regression; Quantitative structure activity relationship.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Feria M, Diaz-Gonzalez F. The CCR2 receptor as a therapeutic target. Expert Opin Ther Pat. 2006;16:49–57.
 
- 
    - Bachmann MF, Kopf M, Marsland BJ. Chemokines: more than just road signs. Nat Rev Immunol. 2006;6:159–164. - PubMed
 
- 
    - Carter PH. Chemokine receptor antagonism as an approach to anti-inflammatory therapy: ’just right’ or plain wrong? Curr Opin Chem Biol. 2002:6510–6525. - PubMed
 
- 
    - Gao Z, Metz WA. Unraveling the chemistry of chemokine receptor ligands. Chem Rev. 2003;103:3733–3752. - PubMed
 
- 
    - Schwarz MK, Wells TN. New therapeutics that modulate chemokine networks. Nat Rev Drug Disc. 2002;1:347–358. - PubMed
 
LinkOut - more resources
- Full Text Sources
